Outsourced testing services sales will grow through 2036, led by contract research organizations at 51.7% of end-user revenue in 2026. Clinical trials testing and bioanalytical testing hold 21.7% of service type demand in 2026. The market is likely to stand at USD 48.2 billion in 2026 and USD 98.9 billion by 2036.